Hsiri Therapeutics

Headquarters

Media, PA

Hsiri Therapeutics is a private biopharmaceutical company dedicated to discovering and developing novel antibiotics to treat multi-drug resistant infections, with a focus on gram-negative bacteria and mycobacterial diseases. The company's research efforts are focused on infections due to mycobacteria, usual bacterial pathogens resistant to current treatments, and drug-resistant fungal pathogens.

• Evrys BioEvrys Bio is a privately held biotech focused on developing first-in-class antiviral therapies that target host cell sirtuin proteins to treat a broad spectrum of viruses and prevent drug resistance. The company is developing allosteric small molecule SIRT2 modulators and has a clinic-ready asset (EV-100) poised for proof-of-concept data.DOYLESTOWN, PA
• GSKGSK is a focused biopharma company that discovers, develops, and delivers medicines and vaccines to create value for patients and shareholders. The company aims to positively impact the health of 2.5 billion people by the end of the decade, with R&D focus on respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.PENNSYLVANIA, PA
• RP
  Ranedis PharmaceuticalsRanedis Pharmaceuticals is a private biopharmaceutical company focused on the treatment and management of rare and neglected diseases, with initial efforts focused on lysosomal storage diseases.MEDIA, PA
• ST
  SRIN TherapeuticsSRIN Therapeutics is advancing novel treatment options for patients by harnessing the power of the endocannabinoid system. The company focuses on biotechnology and pharmaceuticals.PHILADELPHIA, PA